Published in Cancer Weekly, September 18th, 1995
Twenty-nine patients have entered the Phase I/II trial which began October 1994 at the U.S. National Institute of Allergy and Infectious Diseases (NIAID). The Phase II portion of this trial is expected to begin later in 1995 after review of Phase I safety results.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.